To: SSP who wrote (60512 ) 8/28/2000 10:53:42 AM From: StocksDATsoar Read Replies (1) | Respond to of 150070 DNAP..WEEEEEEEEEEEEEEEE!!!!!!!!!!!!!ragingbull.altavista.com By: froomergator $$$ Reply To: None Monday, 28 Aug 2000 at 10:48 AM EDT Post # of 5710 Concerns about the float and potential share price Some insight into possible appreciation of DNAP shares might come from looking at Celera (CRA), a company which I understand is a leader in genomic research and databases. CRA has issued about 57 million shares, approximately ¼ the number for DNAP. Projected revenues for 2000 are $57 mm, but losses will be $90 mm. CRA currently costs a little under $100, but was as high as $276 this year. Assuming DNAP becomes as prominent as CRA, DNAP's stock price could range from $25 - $70. Assuming DNAP becomes, or is perceived by the investing public, as being 1/10th a CRA, the share price is $2.50 - $7.50. As far as I’m concerned, I’m going to be ecstatic when DNAP hits $1.00! I think the valuation of CRA just based on revenues and earnings is out of whack. No technology stock would cost $100 with these numbers. Maybe 9 months ago a technology stock would when technology investing was all about potential and future revenues and earnings. Maybe a FO stock today costs $100 with these numbers because FO is a super hot sector. We’re fortunate to have a stock here that’s going to ride the crest of the genomics wave which many say will be bigger than the Internet and bigger than fiber optics. I think concerns about DNAP’s float depend on your expectations. If you’re looking for over $10 a share, the float will probably be an issue. If you’re looking for $1-$2, I don’t think it will be. (Voluntary Disclosure: Position- Long)